Pacific Biosciences of CaliforniaPACB

PACB current price
$2.05-79.24%

Capital at risk.

1W
-0.49%
1M
+4.06%
3M
+5.95%
6M
+17.37%
1Y
-79.24%
MAX
-71.92%
About Pacific Biosciences of California
Ticker
info
PACB
Trading on
info
NASDAQ
ISIN
info
US69404D1081
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
Christian O. Henry M.B.A.
Headquarters
info
1305 O’Brien Drive, Menlo Park, CA, United States, 94025
Employees
info
796
Website
info
pacb.com
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
Metrics
BasicAdvanced
Market cap
info
$668M
P/E ratio
info
-
EPS
info
-$1.46
Dividend Yield
info
0.00%
Beta
info
2.01
Forward P/E ratio
info
0
EBIDTA
info
$-243M
Ex dividend date
info
-
Price & volume
Market cap
info
$668M
Average daily volume
info
10.4M
90-day return
info
5.95%
30-day return
info
4.06%
7-day return
info
-0.49%
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-0.17
Trailing P/E
info
0
Price to sales
info
3.86
Price to book
info
1.47
Earnings
EPS
info
-$1.46
EPS estimate (current quarter)
info
-$0.22
EPS estimate (next quarter)
info
-$0.20
EBITDA
info
$-243M
Revenues (TTM)
info
$173M
Revenues per share (TTM)
info
$0.64
Technicals
Beta
info
2.01
52-week High
info
$10.65
52-week Low
info
$1.16
50-day moving average
info
$1.96
200-day moving average
info
$2.12
Short ratio
info
4.46
Short %
info
21.05%
Management effectiveness
ROE (TTM)
info
64.80%
ROA (TTM)
info
10.61%
Profit margin
info
227.69%
Gross profit margin
info
$53.5M
Operating margin
info
140.13%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
28.20%
Share stats
Outstanding Shares
info
294M
Float
info
272M
Insiders %
info
9.32%
Institutions %
info
84.58%
Analyst Insights & forecasts
info

47% Buy

53% Hold

0% Sell

Based on information from 15 analysts.

Average price target

info
$3.02
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.31
-$0.29
6.90%
Q4 • 23Beat
-$0.29
-$0.28
3.57%
Q1 • 24Beat
-$0.64
-$0.23
178.26%
Q2 • 24Beat
-$0.22
-$0.22
-
Q3 • 24Beat
-
-
-
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$36M
$-173M
481.27%
Q2 • 24
$40M
$-60.7M
151.94%
Q3 • 24
10.98%
64.96%
68.43%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$1.51B
$1.02B
67.36%
Q2 • 24
$1.45B
$997M
68.75%
Q3 • 24
3.94%
1.95%
2.07%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-54.3M
$76.8M
$-0.2M
$-55.7M
Q2 • 24
$-45.5M
$23.1M
$0.8M
$-44.7M
Q3 • 24
16.22%
69.98%
634.21%
19.85%
QoQ growth
QuarterlyAnnual
Sentiment analysis

-1.5

Extreme greed

+1.5

1.50

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Pacific Biosciences of California share?
Collapse

Pacific Biosciences of California shares are currently traded for $2.05 per share.

How many shares does Pacific Biosciences of California have?
Collapse

Pacific Biosciences of California currently has 294M shares.

Does Pacific Biosciences of California pay dividends?
Collapse

No, Pacific Biosciences of California doesn't pay dividends.

What is Pacific Biosciences of California 52 week high?
Collapse

Pacific Biosciences of California 52 week high is $10.65.

What is Pacific Biosciences of California 52 week low?
Collapse

Pacific Biosciences of California 52 week low is $1.16.

What is the 200-day moving average of Pacific Biosciences of California?
Collapse

Pacific Biosciences of California 200-day moving average is $2.12.

Who is Pacific Biosciences of California CEO?
Collapse

The CEO of Pacific Biosciences of California is Christian O. Henry M.B.A..

How many employees Pacific Biosciences of California has?
Collapse

Pacific Biosciences of California has 796 employees.

What is the market cap of Pacific Biosciences of California?
Collapse

The market cap of Pacific Biosciences of California is $668M.

What is the P/E of Pacific Biosciences of California?
Collapse

The current P/E of Pacific Biosciences of California is null.

What is the EPS of Pacific Biosciences of California?
Collapse

The EPS of Pacific Biosciences of California is -$1.46.

What is the PEG Ratio of Pacific Biosciences of California?
Collapse

The PEG Ration of Pacific Biosciences of California is -0.17.

What do analysts say about Pacific Biosciences of California?
Collapse

According to the analysts Pacific Biosciences of California is considered a hold.